Gonadorelin (gonadotropin-releasing hormone; GnRH) is a decapeptide synthesized in hypothalamic neurons of the arcuate and preoptic nuclei and released in coordinated pulses into the hypophyseal portal circulation. As a synthetic sequence-identical analog, Gonadorelin acts directly on GnRH receptors (GnRHR) — Gq-protein-coupled GPCRs — expressed on pituitary gonadotroph cells. Upon GnRHR binding, Gonadorelin activates phospholipase C (PLC), generating IP3 and DAG second messengers that mobilize intracellular calcium from the endoplasmic reticulum and activate protein kinase C (PKC). The resulting calcium transient drives exocytosis of LH and FSH from gonadotroph secretory granules. GnRH pulse frequency and amplitude strongly determine the LH:FSH ratio released — a pulse-frequency encoding mechanism that Gonadorelin allows researchers to dissect under controlled experimental conditions. Because Gonadorelin is sequence-identical to endogenous GnRH (unlike modified analogs such as Triptorelin or Leuprolide), it has a short half-life due to rapid proteolytic degradation by endopeptidases and aminopeptidases. This property makes it useful for studying acute GnRHR activation and pituitary responses without the receptor desensitization or downregulation associated with long-acting analogs. Key research applications include: pulsatile GnRH secretion modeling, pituitary GnRHR pharmacology, LH and FSH secretion dynamics, and HPG cascade relay studies when combined with upstream compounds like Kisspeptin-10 (which activates hypothalamic GnRH neurons via KISS1R) to study consecutive signaling steps in the same experimental model.
Gonadorelin: Synthetic GnRH Research Guide
Gonadorelin is a synthetic decapeptide identical in sequence to endogenous GnRH. Researchers use it to directly activate pituitary GnRH receptors (GnRHR) and study LH/FSH secretion dynamics in the HPG axis.